The effect of Ribes khorassanicum in diabetes treatment
- Conditions
- type 2 Diabetes.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2017030432857N1
- Lead Sponsor
- Vice chancellor for research, Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Age between 35-60, with 6 month diagnosed diabetes (FBS=126 mg/dL, Blood sugar, 2-h post-prandial = 200 mg/dL and HbA1c = 6.5) and used anti-diabetic drug.
Exclusion criteria: Patients with cardiac, renal, and hepatic diseases, patients who had concomitant infections, insulin injection, smoking, pregnancy and breast-feeding, patients with recent (in the last month) and concurrent use of herbal medications, aspirin, anticoagulant drug and any report of probable side effect of this study intervention.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FBS. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Enzymatic kit.;2-h post-prandial. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Enzymatic kit.;HbA1c. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Enzymatic kit.;Fasting insulin. Timepoint: Before intervention, 3 month after intervention. Method of measurement: ELISA kit.
- Secondary Outcome Measures
Name Time Method Hepatic Enzymes. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Enzymatic kit.;Creatinine. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Enzymatic kit.;Fasting blood levels of lipids. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Enzymatic kit.;Body mass index. Timepoint: Before intervention, 3 month after intervention. Method of measurement: height (cm), weight (kg), BMI (kg/square meters).;Blood pressure. Timepoint: Before intervention, 3 month after intervention. Method of measurement: Sphygmomanometer.